Xuanhua Xie

Xuanhua Xie

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2022 in Developmental Cell
Verified
Journal Article
Closed access
Xuanhua XieXuanhua Xie
Xuanhua Xie
DLDan R. Laks
Dan R. Laks
DSDaochun Sun
Daochun Sun
MGMungunsarnai Ganbold
Mungunsarnai Ganbold
ZWZilai Wang
Zilai Wang
LPLuis F. Parada
Luis F. Parada

23 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Xuanhua XieXuanhua Xie
Xuanhua Xie
DLDan R. Laks
Dan R. Laks
DSDaochun Sun
Daochun Sun
APAsaf Poran
Asaf Poran
ALAshley M. Laughney
Ashley M. Laughney
LPLuis F. Parada
Luis F. Parada
Significance: Adult neural stem cells (NSC) are closely related to multiple neurological disorders and brain tumors. Comprehensive investigation of their composition, lineage, and aging will provide insights that may lead to enhanced patient treatment. This study applies a transgene to label and manipulate neural stem/progenitor cells and monitor their evolution during aging. Together with high-throughput single-cell RNA sequencing, we are able to analyze the subventricular zone cells from infancy to advanced age with unprecedented granularity. Diverse cell states are identified in the stem-cell niche, and an aging-related NSC deficiency in transition from quiescence to proliferation is identified. The related biological features provide rich resources to inspect adult NSC maintenance and neurogenesis.

1 August 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
DSDaochun Sun
Daochun Sun
Xuanhua XieXuanhua Xie
Xuanhua Xie
XZXiyuan Zhang
Xiyuan Zhang
ZWZilai Wang
Zilai Wang
SSSameer Farouk Sait
Sameer Farouk Sait
LPLuis F. Parada
Luis F. Parada

20 November 2024 in Nature
Verified
Journal Article
Closed access
PDF file
YCYu-Jung Chen
Yu-Jung Chen
SISwathi V. Iyer
Swathi V. Iyer
DHDavid Chun-Cheng Hsieh
David Chun-Cheng Hsieh
BLBuren Li
Buren Li
HEHarold K. Elias
Harold K. Elias
LPLuis F. Parada
Luis F. Parada

6 November 2024 in Neuron
Verified
Journal Article
Closed access
Xuanhua XieXuanhua Xie
Xuanhua Xie
MGMungunsarnai Ganbold
Mungunsarnai Ganbold
JLJing Li
Jing Li
MLMichelle Lien
Michelle Lien
MCMollie E. Chipman
Mollie E. Chipman
LPLuis F. Parada
Luis F. Parada

30 December 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SSSameer Farouk Sait
Sameer Farouk Sait
KTKwan Ho Tang
Kwan Ho Tang
SASteven P. Angus
Steven P. Angus
Rebecca M BrownRebecca M Brown
Rebecca M Brown
DSDaochun Sun
Daochun Sun
LPLuis F. Parada
Luis F. Parada
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). These malignancies develop within preexisting benign lesions called plexiform neurofibromas (PNs). PNs are solely driven by biallelic NF1 loss eliciting RAS pathway activation, and they respond favorably to MEK inhibitor therapy. MPNSTs harbor additional mutations and respond poorly to MEK inhibition. Our analysis of genetically engineered and orthotopic patient-derived xenograft MPNST models indicates that MEK inhibition has poor antitumor efficacy. By contrast, upstream inhibition of RAS through the protein-tyrosine phosphatase SHP2 reduced downstream signaling and suppressed NF1 MPNST growth, although resistance eventually emerged. To investigate possible mechanisms of acquired resistance, kinomic analyses of resistant tumors were performed, and data analysis identified enrichment of activated autophagy pathway protein kinases. Combining SHP2 inhibition with hydroxychloroquine (HQ) resulted in durable responses in NF1 MPNSTs in both genetic and orthotopic xenograft mouse models. Our studies could be rapidly translated into a clinical trial to evaluate SHP2 inhibition in conjunction with HQ as a unique treatment approach for NF1 MPNSTs.